Wealthspire Advisors (New York)’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,349
| Closed | -$211K | – | 595 |
|
|
2023
Q2 | $211K | Sell |
1,349
-193
| -13% | -$30.1K | ﹤0.01% | 521 |
|
|
2023
Q1 | $250K | Hold |
1,542
| – | – | ﹤0.01% | 467 |
|
|
2022
Q4 | $246K | Hold |
1,542
| – | – | ﹤0.01% | 495 |
|
|
2022
Q3 | $217K | Sell |
1,542
-3,365
| -69% | -$474K | ﹤0.01% | 464 |
|
|
2022
Q2 | $715K | Sell |
4,907
-7,942
| -62% | -$1.16M | 0.01% | 262 |
|
|
2022
Q1 | $2.08M | Sell |
12,849
-1,735
| -12% | -$281K | 0.05% | 122 |
|
|
2021
Q4 | $2.76M | Sell |
14,584
-874
| -6% | -$165K | 0.06% | 115 |
|
|
2021
Q3 | $3.13M | Sell |
15,458
-497
| -3% | -$100K | 0.06% | 120 |
|
|
2021
Q2 | $3.22M | Buy |
15,955
+7,367
| +86% | +$1.49M | 0.08% | 83 |
|
|
2021
Q1 | $1.51M | Buy |
8,588
+1,293
| +18% | +$227K | 0.04% | 208 |
|
|
2020
Q4 | $1.24M | Buy |
7,295
+68
| +0.9% | +$11.5K | 0.04% | 181 |
|
|
2020
Q3 | $1.17M | Buy |
7,227
+4,475
| +163% | +$725K | 0.07% | 115 |
|
|
2020
Q2 | $448K | Buy |
+2,752
| New | +$448K | 0.03% | 162 |
|